Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus
Clinical trial NCT03527472 · COMPLETED
Trial details
- NCT number
- NCT03527472
- Sponsor
- Vanderbilt University Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-23
- Primary completion
- 2026-02-28
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.